Search research articles
Contact Us
Filters
Showing results (11-20 of 77) with videos related to
Page
of 8
Sort By:
Brain Research
|
May 25, 1996
Serotonergic lesioning differentially affects presynaptic and postsynaptic 5-HT1B receptor mRNA levels in rat brain
J F Neumaier, P Szot, E R Peskind, et al.
Neuroendocrinology
|
September 1, 1989
Yohimbine increases cerebrospinal fluid and plasma norepinephrine but not arginine vasopressin in humans
E R Peskind, R C Veith, D M Dorsa, et al.
Neurobiology of Aging
|
July 11, 2001
Increased alpha 2-adrenergic receptor binding in locus coeruleus projection areas in dementia with Lewy bodies
J B Leverenz, M A Miller, D J Dobie, et al.
Neurology
|
April 26, 2001
Increased CSF cortisol in AD is a function of APOE genotype
E R Peskind, C W Wilkinson, E C Petrie, et al.
Psychoneuroendocrinology
|
November 23, 2000
Plasma catecholamine and cardiovascular responses to physostigmine in Alzheimer's disease and aging
E C Petrie, E R Peskind, D J Dobie, et al.
Journal of Neurochemistry
|
October 28, 1999
Preservation of noradrenergic neurons in the locus ceruleus that coexpress galanin mRNA in Alzheimer's disease
M A Miller, P E Kolb, J B Leverenz, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
May 5, 2000
Increased plasma norepinephrine response to yohimbine in elderly men
E C Petrie, E R Peskind, D J Dobie, et al.
Biological Psychiatry
|
January 15, 1997
The effect of apolipoprotein E genotype on expression of an autosomal dominant schizophreniform disorder with progressive dementia and neurofibrillary tangles
D Tsuang, M A Raskind, J Leverenz, et al.
European Journal of Clinical Pharmacology
|
January 1, 1997
Cerebrospinal fluid and plasma disposition of yohimbine and 11-hydroxy-yohimbine in young and older healthy subjects, and Alzheimer's disease patients
P A Le Corre, E R Peskind, F Chevanne, et al.
Brain Research
|
March 5, 1986
Peripheral sympathectomy and adrenal medullectomy do not alter cerebrospinal fluid norepinephrine
E R Peskind, M A Raskind, C W Wilkinson, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 77) with videos related to
Sort By:
Page
of 8
Brain Research
|
May 25, 1996
Serotonergic lesioning differentially affects presynaptic and postsynaptic 5-HT1B receptor mRNA levels in rat brain
J F Neumaier, P Szot, E R Peskind, et al.
Neuroendocrinology
|
September 1, 1989
Yohimbine increases cerebrospinal fluid and plasma norepinephrine but not arginine vasopressin in humans
E R Peskind, R C Veith, D M Dorsa, et al.
Neurobiology of Aging
|
July 11, 2001
Increased alpha 2-adrenergic receptor binding in locus coeruleus projection areas in dementia with Lewy bodies
J B Leverenz, M A Miller, D J Dobie, et al.
Neurology
|
April 26, 2001
Increased CSF cortisol in AD is a function of APOE genotype
E R Peskind, C W Wilkinson, E C Petrie, et al.
Psychoneuroendocrinology
|
November 23, 2000
Plasma catecholamine and cardiovascular responses to physostigmine in Alzheimer's disease and aging
E C Petrie, E R Peskind, D J Dobie, et al.
Journal of Neurochemistry
|
October 28, 1999
Preservation of noradrenergic neurons in the locus ceruleus that coexpress galanin mRNA in Alzheimer's disease
M A Miller, P E Kolb, J B Leverenz, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
May 5, 2000
Increased plasma norepinephrine response to yohimbine in elderly men
E C Petrie, E R Peskind, D J Dobie, et al.
Biological Psychiatry
|
January 15, 1997
The effect of apolipoprotein E genotype on expression of an autosomal dominant schizophreniform disorder with progressive dementia and neurofibrillary tangles
D Tsuang, M A Raskind, J Leverenz, et al.
European Journal of Clinical Pharmacology
|
January 1, 1997
Cerebrospinal fluid and plasma disposition of yohimbine and 11-hydroxy-yohimbine in young and older healthy subjects, and Alzheimer's disease patients
P A Le Corre, E R Peskind, F Chevanne, et al.
Brain Research
|
March 5, 1986
Peripheral sympathectomy and adrenal medullectomy do not alter cerebrospinal fluid norepinephrine
E R Peskind, M A Raskind, C W Wilkinson, et al.
Page
of 8